Erdal, HüseyinYaşar, ErdoğanTuncer, Sibel Ciğdem2024-05-032024-05-0320232667-663Xhttps:/dx.doi.org10.4328/ACAM.21474https://hdl.handle.net/20.500.12451/11756Aim: The aim of the present study is to determine the calprotectin levels in patients with cataract surgery. Material and Methods: This prospective study included 60 people, including 30 cataracts and 30 controls. Serum Calprotectin levels were determined in the ELx-800 (BioTek((R))) device using a commercial ELISA kit. Results: Serum calprotectin levels in the cataract group were significantly higher than in the control group (p=0.001). Furthermore, we also found that calprotectin levels were significantly higher after cataract surgery than before cataract surgery (p=0.01). We found that Neutrophil-lymphocyte ratio (NLR) was higher, but no statistically significant difference was observed after cataract surgery compared to the controls (p=0.07). Discussion: This study revealed that serum calprotectin levels can be used as a possible inflammation biomarker in the follow-up of inflammation caused by cataract surgery and also in the follow- up of cataract progression.eninfo:eu-repo/semantics/openAccessCalprotectinCataractInflammationNeutrophil-lymphocyte RatioCataract SurgeryArticle14214815110.4328/ACAM.21474N/A